Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rilas Technologies is a private Massachusetts-based analytical chemistry and purification CRO serving biotech and pharmaceutical customers. Founded in 2009, the company provides contract analytical chemistry, preparative and analytical purification, method development, LC-MS, HPLC, SFC, and biomolecule characterization services. Rilas supports drug discovery through late-stage preclinical development, with capabilities spanning small molecules, peptides, proteins, antibodies, and oligonucleotides. The company also offers consulting, insourcing support, and incubator space for emerging biotech companies. Its business is service-based rather than centered on a proprietary therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rilas Technologies.